ALNY
Price
$460.76
Change
-$1.54 (-0.33%)
Updated
Nov 19 closing price
Capitalization
60.87B
84 days until earnings call
Intraday BUY SELL Signals
ALXO
Price
$1.47
Change
-$0.16 (-9.82%)
Updated
Nov 19 closing price
Capitalization
88.38M
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALNY vs ALXO

Header iconALNY vs ALXO Comparison
Open Charts ALNY vs ALXOBanner chart's image
Alnylam Pharmaceuticals
Price$460.76
Change-$1.54 (-0.33%)
Volume$893.89K
Capitalization60.87B
ALX Oncology Holdings
Price$1.47
Change-$0.16 (-9.82%)
Volume$286.89K
Capitalization88.38M
ALNY vs ALXO Comparison Chart in %
ALNY
Daily Signal:
Gain/Loss:
ALXO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALNY vs. ALXO commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Hold and ALXO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ALNY: $460.76 vs. ALXO: $1.47)
Brand notoriety: ALNY and ALXO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 83% vs. ALXO: 53%
Market capitalization -- ALNY: $60.87B vs. ALXO: $88.38M
ALNY [@Biotechnology] is valued at $60.87B. ALXO’s [@Biotechnology] market capitalization is $88.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 2 FA rating(s) are green whileALXO’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 2 green, 3 red.
  • ALXO’s FA Score: 0 green, 5 red.
According to our system of comparison, ALNY is a better buy in the long-term than ALXO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 7 TA indicator(s) are bullish while ALXO’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 7 bullish, 3 bearish.
  • ALXO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALNY is a better buy in the short-term than ALXO.

Price Growth

ALNY (@Biotechnology) experienced а +1.77% price change this week, while ALXO (@Biotechnology) price change was +14.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

ALNY is expected to report earnings on Feb 12, 2026.

ALXO is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($60.9B) has a higher market cap than ALXO($88.4M). ALNY YTD gains are higher at: 95.810 vs. ALXO (-11.976). ALNY has higher annual earnings (EBITDA): 187M vs. ALXO (-114.05M). ALNY has more cash in the bank: 2.73B vs. ALXO (79.3M). ALXO has less debt than ALNY: ALXO (10M) vs ALNY (1.31B). ALNY has higher revenues than ALXO: ALNY (3.21B) vs ALXO (0).
ALNYALXOALNY / ALXO
Capitalization60.9B88.4M68,891%
EBITDA187M-114.05M-164%
Gain YTD95.810-11.976-800%
P/E Ratio1535.87N/A-
Revenue3.21B0-
Total Cash2.73B79.3M3,436%
Total Debt1.31B10M13,080%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
8
SMR RATING
1..100
29
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
39
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYALXO
RSI
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
63%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
72%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signal:
Gain/Loss:
ALXO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WDFN25.50N/A
N/A
Woodlands Financial Services Co.
KACLF0.35N/A
N/A
Kairous Acquisition Corp.
OCPNF14.00N/A
N/A
Olympus Corp.
NWBO0.24-0.01
-2.54%
Northwest Biotherapeutics, Inc.
KURRY29.10-1.48
-4.82%
Kuraray Co.

ALXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
-9.82%
MDGL - ALXO
56%
Loosely correlated
-0.61%
AXON - ALXO
45%
Loosely correlated
-0.50%
AMRN - ALXO
43%
Loosely correlated
+1.08%
ALNY - ALXO
39%
Loosely correlated
-0.33%
VERA - ALXO
36%
Loosely correlated
-1.25%
More